StockMacro
Menu

Sinovac Biotech

SVA on XNAS, Sinovac Biotech, Ltd, job postings

Measures activity, not value. Not investment advice.

Institutional filers dropped from 28 to 7 while free cash outflow hit $561.1M in 12 months.

  • WatchRevenue up 6.8% over 12 months, but net loss of $198.8M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 31 Dec 2025

Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines for the prevention of human infectious diseases, including certain diseases with unmet medical needs. It has developed a comprehensive vaccine portfolio covering hepatitis A, hepatitis B, hand, foot and mouth disease ("HFMD") caused by enterovirus 71 ("EV71"), seasonal and pandemic influenza, COVID-19, pneumococcal disease, poliomyelitis, mumps, varicella, rabies and tetanus. The Company operates exclusively in the research, development, manufacture, and commercialization of vaccines sector. The Company's business is considered as operating in one segment. It has presence in Chinese Mainland, and Outside Chinese Mainland.

Employees
2,602
Website
sinovac.com
Listed
Nasdaq, US
Fundamentals, 12 months to 31 Dec 2025
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $386.0M $361.4M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +6.8%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$198.8M $40.7M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 67.9% 61.1%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -127% -140%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -51.5% 11.3%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -3.1%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$561.1M -$152.9M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $6.0B $9.9B
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. –
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss
P/SPrice to sales: market cap divided by revenue of the last 12 months. –
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. –
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. –

Latest = 12 months to 31 Dec 2025; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-75%

7 13F filers vs 28

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

4.3%

3.1M shares held by 13F filers (30 Sep 2026) of 71.9M outstanding (31 Dec 2025)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

0.1%

82K shares sold short (30 Oct 2026) of 71.9M outstanding (31 Dec 2025)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

–

82K shares sold short (30 Oct 2026); FINRA gives no days to cover without an average volume

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

0%

82K shares sold short in the report before, 82K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

–

No FINRA daily short sale volume in the last 10 days.

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

0

0 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

0 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

No prices from the host for this ticker

  • Sharp change
  • 8-K and other filings
Institutional holders (13F filers). 7 13F filers reported holding it in the latest 13F quarter, -73% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: insider net buying (open market), h-1b/e-3 applications certified, revenue per quarter, capital spending per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
30 Apr 20268-K and other filingsReport will be filed late
14 Aug 2025Sharp changeMany funds opening a new position: many funds opening a new position, 22 vs usual 0 (2025-06-30); 7.3x the same period a year earlier
29 Apr 20258-K and other filingsReport will be filed late
15 Aug 2023Sharp changeMany funds opening a new position: many funds opening a new position, 23 vs usual 1 (2023-06-30); 1.1x the same period a year earlier
16 Aug 2022Sharp changeMany funds opening a new position: many funds opening a new position, 21 vs usual 1 (2022-06-30)
Institutional holders (13F filers)
31 Dec 2021 report: 28; public on 14 Feb 2022
31 Mar 2022 report: 10; public on 16 May 2022
30 Jun 2022 report: 30; public on 15 Aug 2022
30 Sep 2022 report: 28; public on 14 Nov 2022
31 Dec 2022 report: 9; public on 14 Feb 2023
31 Mar 2023 report: 4; public on 15 May 2023
30 Jun 2023 report: 27; public on 14 Aug 2023
30 Sep 2023 report: 28; public on 14 Nov 2023
31 Dec 2023 report: 7; public on 14 Feb 2024
31 Mar 2024 report: 26; public on 15 May 2024
30 Jun 2024 report: 25; public on 14 Aug 2024
30 Sep 2024 report: 9; public on 14 Nov 2024
31 Dec 2024 report: 4; public on 14 Feb 2025
31 Mar 2025 report: 3; public on 15 May 2025
30 Jun 2025 report: 26; public on 14 Aug 2025
30 Sep 2025 report: 26; public on 14 Nov 2025
31 Dec 2025 report: 28; public on 17 Feb 2026
31 Mar 2026 report: 28; public on 15 May 2026
30 Jun 2026 report: 28; public on 14 Aug 2026
30 Sep 2026 report: 7; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is net change in 13F-reported shares at -7.4M (30 Sep 2026), 104620% below its normal reading of -7,031; higher than 6% of its own history.
  • Institutional holders (13F filers): 7 13F filers reported holding it in the latest 13F quarter, -73% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

7 institutions reported shares at the end of Q3 2026, 4% of the shares outstanding; 0 opened a position, 21 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Orbimed Advisors LLC2.7M3.78%$195.5MNo change
Neumann Advisory Hong Kong Ltd316K0.44%$2KNo change
California Public Employees Retirement System69K0.10%No change
IFP Advisors, Inc2000.00%No change
Horizon Investments, LLC520.00%$336No change
Financial Gravity Asset Management, Inc.110.00%
Transamerica Financial Advisors, LLC10.00%No change

Company events

All 4 company events

In 12 months: 1 late report. Results releases and routine reports are left out.

FiledWhat happenedSource
30 Apr 2026Quarterly report will be filed lateNT 20-F
29 Apr 2025Quarterly report will be filed lateNT 20-F
30 Apr 2018Quarterly report will be filed lateNT 20-F
1 May 2017Quarterly report will be filed lateNT 20-F

The 5 newest of 47 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 30 Apr 2026Filings record

    Report will be filed late

  2. 14 Aug 2025Institutional holdings change

    saw 22 13F filers open a new position in the quarter ended 30 Jun 2025, 7.3× the same quarter last year.

    Same quarter last year: 3; its normal quarter is 0.

    See the evidence
    This period
    22 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    0
    Typical spread (median absolute deviation)
    0
    How far from its usual level
    +7.3
    Same quarter last year
    3
    History used
    4,291 days
    2023-06-30: 232023-09-30: 02023-12-31: 02024-03-31: 182024-06-30: 32024-09-30: 02024-12-31: 02025-03-31: 02025-06-30: 22
    the quarter ended 30 Jun 20258 earlier quartersnormal: 0

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  3. 29 Apr 2025Filings record

    Report will be filed late

  4. 14 Aug 2023Institutional holdings change

    saw 23 13F filers open a new position in the quarter ended 30 Jun 2023, 1.1× the same quarter last year.

    Same quarter last year: 21; its normal quarter is 1.

    See the evidence
    This period
    23 (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    1
    Typical spread (median absolute deviation)
    1
    How far from its usual level
    +7.3
    Same quarter last year
    21
    History used
    3,560 days
    2021-06-30: 02021-09-30: 22021-12-31: 12022-03-31: 12022-06-30: 212022-09-30: 12022-12-31: 02023-03-31: 02023-06-30: 23
    the quarter ended 30 Jun 20238 earlier quartersnormal: 1

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  5. 15 Aug 2022Institutional holdings change

    saw 21 13F filers open a new position in the quarter ended 30 Jun 2022, against none in the same quarter last year.

    See the evidence
    This period
    21 (the quarter ended 30 Jun 2022)
    Normal quarter (median of 8 earlier)
    1
    Typical spread (median absolute deviation)
    1
    How far from its usual level
    +6.7
    Same quarter last year
    0
    History used
    3,195 days
    2020-06-30: 02020-09-30: 42020-12-31: 02021-03-31: 22021-06-30: 02021-09-30: 22021-12-31: 12022-03-31: 12022-06-30: 21
    the quarter ended 30 Jun 20228 earlier quartersnormal: 1

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  6. 15 Dec 2020Attention change

    drew 11K Wikipedia page views in the week of 7 Dec 2020, 196× the same week last year.

    Same week last year: 57; its normal week is 2,299.

    See the evidence
    This period
    11K (the week of 7 Dec 2020)
    Normal week (median of 26 earlier)
    2,299
    Typical spread (median absolute deviation)
    599
    How far from its usual level
    +10.0
    Same week last year
    57
    History used
    712 days
    2020-06-08: 4,2532020-06-15: 2,6072020-06-22: 1,1052020-06-29: 1,3022020-07-06: 2,0962020-07-13: 2,6112020-07-20: 4,7462020-07-27: 2,2552020-08-03: 1,9142020-08-10: 2,6672020-08-17: 2,4042020-08-24: 2,3432020-08-31: 1,8522020-09-07: 2,5792020-09-14: 2,1482020-09-21: 2,0522020-09-28: 1,3682020-10-05: 1,0392020-10-12: 1,7932020-10-19: 4,1212020-10-26: 1,6072020-11-02: 1,1502020-11-09: 5,1682020-11-16: 4,0682020-11-23: 4,0002020-11-30: 5,4762020-12-07: 11K
    the week of 7 Dec 202026 earlier weeksnormal: 2,299

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  7. 30 Apr 2018Filings record

    Report will be filed late

  8. 1 May 2017Filings record

    Report will be filed late

Not listed: 11 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001084201
Ticker
SVA
Domain
sinovac.com
Hq location
|BEIJING|10008 (1 unverified)
Name
NET FORCE SYSTEMS INC, Sinovac Biotech, Ltd
Wikidata
Q3485048
Wikipedia
Sinovac Biotech
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)15 records25 Apr 2016 to 5 Jun 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)286 data points31 Dec 2008 to 31 Dec 2025
  • FINRA short interest (twice monthly)441 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)280 data points1 Aug 2018 to 22 Feb 2019
  • Wikipedia pageviews2881 data points1 Jan 2019 to 20 Nov 2026